J7677
HCPCSRevefenacin inh non-com 1mcg
Official HCPCS Level II long descriptor
Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram
HCPCS Level II code J7677 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Revefenacin inh non-com 1mcg
Added to HCPCS: 2019-07-01
Nearby codes in J7
- J7660Isoproterenol comp unit
- J7665Mannitol for inhaler
- J7667Metaproterenol comp con
- J7668Metaproterenol non-comp con
- J7669Metaproterenol non-comp unit
- J7670Metaproterenol comp unit
- J7674Methacholine chloride, neb
- J7676Pentamidine comp unit dose
- J7680Terbutaline sulf comp con
- J7681Terbutaline sulf comp unit
- J7682Tobramycin non-comp unit
- J7683Triamcinolone comp con
- J7684Triamcinolone comp unit
- J7685Tobramycin comp unit
- J7686Treprostinil, non-comp unit
- J7699Inhalation solution for dme
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.